S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
Free Trial
NASDAQ:BIOS

BioPlus Acquisition (BIOS) Stock Price, News & Analysis

→ The #1 Opportunity of the decade? (From Behind the Markets) (Ad)
Free BIOS Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$10.79
▼
$10.80
50-Day Range
$10.75
▼
$10.84
52-Week Range
$10.05
▼
$11.68
Volume
5,600 shs
Average Volume
122,781 shs
Market Capitalization
$209.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
BIOS stock logo

About BioPlus Acquisition Stock (NASDAQ:BIOS)

BioPlus Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. BioPlus Acquisition Corp. was incorporated in 2021 and is based in New York, New York.

BIOS Stock News Headlines

April 16, 2024 | markets.businessinsider.com
Imugene and Kincell Bio Announce Strategic Manufacturing and Process Development Partnership
April 3, 2024 | benzinga.com
Louis G Lange's Net Worth
April 19, 2024 | Behind the Markets (Ad)
The #1 Opportunity of the decade?
It's no wonder the Department of Defense is heavily invested in this technology. And why The Pentagon is pouring $20 billion into it.
February 9, 2024 | msn.com
Why Intelligent Bio Solutions Stock Is Ripping Higher
January 22, 2024 | investing.com
BioPlus Co Ltd (099430)
October 4, 2023 | msn.com
SPAC BioPlus, Avertix terminate merger; BioPlus to liquidate
October 4, 2023 | markets.businessinsider.com
Avertix, BIOS Acquisition Agree To Terminate Merger Deal
October 4, 2023 | finance.yahoo.com
Avertix and BIOS Acquisition Corporation Mutually Agree to Terminate Proposed Business Combination
April 19, 2024 | Behind the Markets (Ad)
The #1 Opportunity of the decade?
It's no wonder the Department of Defense is heavily invested in this technology. And why The Pentagon is pouring $20 billion into it.
October 4, 2023 | finance.yahoo.com
BioPlus Acquisition Corp. Announces Termination of Business Combination Agreement with Avertix Medical, Inc. and its Intention to Liquidate
August 16, 2023 | finance.yahoo.com
Heart & Rhythm Institute of Trinity and Avertix Announce Partnership to Improve Cardiac Care and Patient Monitoring
August 16, 2023 | finance.yahoo.com
Avertix Partners with Institute on Implantable Heart Attack Detection System
July 20, 2023 | finance.yahoo.com
Avertix Medical Welcomes Renown Cardiologist to Board of Directors
July 17, 2023 | finance.yahoo.com
Renown Cardiologist and Professor Ian T. Meredith, MD to Join Avertix Medical’s Board of Directors
June 13, 2023 | finance.yahoo.com
Avertix’s Guardian™ System, First and Only FDA-Approved Implantable Heart Attack Detection and Warning System, Now Available at AdventHealth Orlando
May 26, 2023 | seekingalpha.com
BIOS BioPlus Acquisition Corp.
May 5, 2023 | msn.com
SPAC BIOS to merge with cardiac device maker Avertix
May 3, 2023 | finance.yahoo.com
Avertix, Maker of First and Only FDA-Approved Implantable Heart Attack Warning System, to Become Publicly Traded via Merger with BIOS Acquisition Corporation
March 18, 2023 | money.usnews.com
BioPlus Acquisition Corp - Ordinary Shares - Class A
September 23, 2022 | wsj.com
BioPlus Acquisition Corp. Cl A
September 20, 2022 | finance.yahoo.com
BioPlus Acquisition Corp. (BIOS)
September 3, 2022 | investing.com
BioPlus Acquisition Corp (BIOS)
August 13, 2022 | reuters.com
BioPlus Acquisition Corp
August 10, 2022 | finance.yahoo.com
What Type Of Shareholders Own The Most Number of BioPlus Acquisition Corp. (NASDAQ:BIOS) Shares?
See More Headlines
Receive BIOS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioPlus Acquisition and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/19/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Unclassified
Industry
Holding & other investment offices
Sub-Industry
N/A
Current Symbol
NASDAQ:BIOS
CUSIP
N/A
CIK
1856653
Web
bioplusspac.com
Phone
212-287-4092
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
19,370,000
Free Float
14,990,000
Market Cap
$209.20 million
Optionable
Not Optionable
Beta
0.01
7 Stocks to Own Before the 2024 Election Cover
7 Stocks to Own Before the 2024 Election

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

  • Mr. Jonathan M. N. Rigby MBA (Age 55)
    Chairman & Chief Bus. Officer
  • Mr. R. Ross Haghighat (Age 59)
    CEO, CFO & Director

Key Competitors

View All Competitors

BIOS Stock Analysis - Frequently Asked Questions

When did BioPlus Acquisition IPO?

BioPlus Acquisition (BIOS) raised $180 million in an initial public offering (IPO) on Friday, December 3rd 2021. The company issued 18,000,000 shares at $10.00 per share. Cantor served as the underwriter for the IPO.

This page (NASDAQ:BIOS) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
He Is Giving Away Bitcoin
Crypto Swap Profits
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
The #1 Crypto for 2024
InvestorPlace
Your Money is Not Safe
American Alternative